Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers. | Front Cardiovasc Med | 2022 | 35911521 | PubTator, text mining | PubMed |
| Hsa_circ_0129047 regulates the miR-375/ACVRL1 axis to attenuate the progression of lung adenocarcinoma. | J Clin Lab Anal | 2022 | 35908770 | PubTator, text mining | PubMed |
| Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer. | Cell Rep | 2022 | 35905726 | PubTator, text mining | PubMed |
| Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer. | EBioMedicine | 2022 | 35901658 | PubTator, text mining | PubMed |
| Bronchoscopy-guided removal of intrabronchial coil migration after coil embolization of pulmonary arteriovenous malformation. | Radiol Case Rep | 2022 | 35899085 | PubTator, text mining | PubMed |
| Low-Dose-Rate Radiation-Induced Secretion of TGF-β3 Together with an Activator in Small Extracellular Vesicles Modifies Low-Dose Hyper-Radiosensitivity through ALK1 Binding. | Int J Mol Sci | 2022 | 35897723 | PubTator, text mining | PubMed |
| Endothelial Loss of ETS1 Impairs Coronary Vascular Development and Leads to Ventricular Non-Compaction. | Circ Res | 2022 | 35894043 | PubTator, text mining | PubMed |
| Hereditary Hemorrhagic Telangiectasia Associating Neuropsychiatric Manifestations with a Significant Impact on Disease Management-Case Report and Literature Review. | Life (Basel) | 2022 | 35888148 | PubTator, text mining | PubMed |
| Embolization of Recurrent Pulmonary Arteriovenous Malformations by Ethylene Vinyl Alcohol Copolymer (Onyx®) in Hereditary Hemorrhagic Telangiectasia: Safety and Efficacy. | J Pers Med | 2022 | 35887588 | PubTator, text mining | PubMed |
| Anti-CK7/CK20 Immunohistochemistry Did Not Associate with the Metastatic Site in TTF-1-Negative Lung Cancer. | Diagnostics (Basel) | 2022 | 35885495 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM). | Antioxidants (Basel) | 2022 | 35883785 | PubTator, text mining | PubMed |
| Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal Conversion. | Cell Reprogram | 2022 | 35877103 | PubTator, text mining | PubMed |
| Cytokine storm: behind the scenes of the collateral circulation after acute myocardial infarction. | Inflamm Res | 2022 | 35876879 | PubTator, text mining | PubMed |
| Application of Multi-Omics Approach in Sarcomas: A Tool for Studying Mechanism, Biomarkers, and Therapeutic Targets. | Front Oncol | 2022 | 35875106 | PubTator, text mining | PubMed |
| Differential Gene Analysis of Trastuzumab in Breast Cancer Based on Network Pharmacology and Medical Images. | Front Physiol | 2022 | 35874525 | PubTator, text mining | PubMed |
| EPDR1 is a noncanonical effector of insulin-mediated angiogenesis regulated by an endothelial-specific TGF-β receptor complex. | J Biol Chem | 2022 | 35872017 | PubTator, text mining | PubMed |
| WNK1 collaborates with TGF-β in endothelial cell junction turnover and angiogenesis. | Proc Natl Acad Sci U S A | 2022 | 35867836 | PubTator, text mining | PubMed |
| Caveolin-1 associated with severe (pediatric-onset) presentation of pulmonary arterial hypertension. | Pulm Circ | 2022 | 35864912 | PubTator, text mining | PubMed |
| Mural Cell SRF Controls Pericyte Migration, Vessel Patterning and Blood Flow. | Circ Res | 2022 | 35862101 | PubTator, text mining | PubMed |
| Effect of cell receptors in the pathogenesis of osteoarthritis: Current insights. | Open Life Sci | 2022 | 35859614 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers?page=36